Nofazinlimab (Anti-PDCD1 / PD-1 / CD279)
Product Specifications
CAS Number
2377845-98-0
Synonyms
CS1003
SKU
C00693-1mg
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Nofazinlimab (anti-PDCD1/ PD-1 / CD279) is a humanised IgG4 monoclonal antibody targeting PD-1. Nofazinlimab has the potential to be used in unresectable hepatocellular carcinoma (uHCC) research. MW: 145.08 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![4-[3- (Methylsulfonyl) phenyl]-1,2,3,6-tetrahydropyridine](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
282844-01 10 mg
4-[3- (Methylsulfonyl) phenyl]-1,2,3,6-tetrahydropyridine
Sign In for Pricing
View Details ![4-[3- (Methylsulfonyl) phenyl]-1,2,3,6-tetrahydropyridine](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
282844-02 25 mg
4-[3- (Methylsulfonyl) phenyl]-1,2,3,6-tetrahydropyridine
Sign In for Pricing
View Details 282844-03 50 mg
4-[3- (Methylsulfonyl) phenyl]-1,2,3,6-tetrahydropyridine
Sign In for Pricing
View Details 282844-04 100 mg
4-[3- (Methylsulfonyl) phenyl]-1,2,3,6-tetrahydropyridine
Sign In for Pricing
View Details 282844-05 250 mg
4-[3- (Methylsulfonyl) phenyl]-1,2,3,6-tetrahydropyridine
Sign In for Pricing
View Details